Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis

Aquatic Toxicology

Volumn 94, Issue 3, 2009, Pages 177-185

  Martin Diaz, Laura ^a   Franzellitti, Silvia ^b   Buratti, Sara ^b   Valbonesi, Paola ^b   Capuzzo, Antonio ^c   Fabbri, Elena ^b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Biomarkers; cAMP; MXR; Mytilus galloprovincialis; Pharmaceuticals; PKA

Indexed keywords

BIOLOGICAL MARKER; CARBAMAZEPINE; CATALASE; CELL PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; GLUTATHIONE TRANSFERASE; LIPID; LIPOFUSCIN; MESSENGER RNA; PROTEIN MXR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

BIOCHEMISTRY; BIOMARKER; CONCENTRATION (COMPOSITION); DOSE-RESPONSE RELATIONSHIP; DRUG; LIPID; MOLLUSC; OXIDATION; RISK ASSESSMENT; TOXICITY TEST;

ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BLOOD CELL; CONTROLLED STUDY; DNA DAMAGE; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; EXOCRINE GLAND; GENE EXPRESSION; GILL; GONAD; LIPID PEROXIDATION; LYSOSOME; MEMBRANE STABILIZATION; MYTILUS GALLOPROVINCIALIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION; WATER CONTAMINATION; XENOBIOTIC METABOLISM;

ANIMALS; ANTICONVULSANTS; BIOLOGICAL MARKERS; CARBAMAZEPINE; CATALASE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUTATHIONE TRANSFERASE; HEMOCYTES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALONDIALDEHYDE; MYTILUS; OXIDATIVE STRESS; WATER POLLUTANTS, CHEMICAL;

MYTILUS GALLOPROVINCIALIS;

EID: 69249209692     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2009.06.015     Document Type: Article

References (37)

1. Banni M., Dondero F., Jebali J., Guerbej H., Boussetta H., and Viarengo A. Assessment of heavy metal contamination using real-time PCR analysis of mussel metallothionein mt10 and mt20 expression: a validation along the Tunisian coast. Biomarkers 12 (2007) 369-383
2. Bard S.M. Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. Aquat. Toxicol. 48 (2000) 357-389
3. Canesi L., Lorusso L.C., Ciacci C., Betti M., Rocchi M., Pojana G., and Marcomini A. Immunomodulation of Mytilus haemocytes by individual estrogenic chemicals and environmentally relevant mixtures of estrogens: in vitro and in vivo studies. Aquat. Toxicol. 81 (2007) 36-44
4. Chen G., Pan B., Hawver D.B., Wright C.B., Potter W.Z., and Manji H.K. Attenuation of cyclic AMP production by carbamazepine. J. Neurochem. 67 (1996) 2079-2086
5. Clara M., Strenn B., and Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations of the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 38 (2004) 947-954
6. Dailianis S., Domouhtsidou G.P., Raftopoulou E., Kaloyianni M., and Dimitridis V.K. Evaluation of neutral red retention assay, micronucleus test, acetylcholinesterase activity and a signal transduction molecule (cAMP) in tissues of Mytilus galloprovincialis (L.), in pollution monitoring. Mar. Environ. Res. 56 (2003) 443-470
7. Dailianis S., and Kaloyianni M. Role of cAMP in tissues of Mytilus galloprovincialis as a potent biomarker of cadmium in marine environments. Arch. Environ. Contam. Toxicol. 52 (2007) 371-378
8. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle changes?. Environ. Health Perspect. Suppl. 6 (1999) 907-938
9. Diaz-Enrich M.J., Ramos Martinez J.I., and Ibarguren I. Implication of adenosine 3′,5′-cyclic monophosphate, guanosine 3′,5′-cyclic monophosphate, adenosine 5′-mono-, di-, and triphosphate and fructose-2,6-bisphosphate in the regulation of the glycolytic pathway in relation to the ganetogenic cycle in the mussel Mytilus galloprovincialis Lmk. Mol. Cell. Biochem. 252 (2003) 339-345
10. 2+. Aquat. Toxicol. 76 (2006) 59-68
11. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006) 122-159
12. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., and Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewater: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Saf. 55 (2003) 359-370
13. +. Biochem. Biophys. Res. Commun. 351 (2006) 719-725
14. Gagnè F., Blaise C., and Andrè C. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout hepatocytes. Ecotoxicol. Environ. Saf. 64 (2006) 329-336
15. Gagnè F., Blaise C., Andrè C., Gagnon C., and Salazar M. Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment. Chemosphere 68 (2007) 731-743
16. Gagnè F., Blaise C., and Hellou J. Endocrine disruption and health effects of caged mussels, Elliptio complanata, placed downstream from a primary-treated municipal effluent plume for 1 year. Comp. Biochem. Physiol. 138C (2004) 33-44
17. Garcia-Morales I., Sancho Rieger J., Gil-Nagel A., and Herranz Fernandez J.L. Antiepileptic drugs: from a scientific evidence to clinical practice. Neurologist 13 (2007) S20-28
18. Jos A., Repetto G., Rios J.C., Hazen M.J., Molero M.L., Del Peso A., Salguero M., Fernansez-Freire P., Perez-Martin J.M., and Camean A. Ecotoxicological evaluation of carbamazepine using six different model systems with eughteen endpoints. Toxicol. In Vitro 17 (2003) 525-532
19. Koehler A. Toxic injury and gender-specific hepatocellular carcinogenesis in flounder (Platichthys flesus L.). Aquat. Toxicol. 70 (2004) 257-276
20. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Luckenbach T., and Epel D. Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defense systems mediated by multidrug transporters. Environ. Health Perspect. 113 (2005) 17-24
22. Martinez-Gomez C., Benedicto J., Campillo J.A., and Moore M. Application and evaluation of the neutral red retention (NRR) assay for lysosomal stability in mussel populations along the Iberian Mediterranean coast. J. Environ. Monit. 10 (2008) 490-499
23. Martin-Diaz M.L., Blasco J., Sales D., and DelValls T.A. Biomarkers study for sediment quality assessment in spanish ports using the crab Carcinus maenas and the clam Ruditapes philippinarum. Arch. Environ. Contam. Toxicol. 53 (2007) 66-76
24. Mimeault C., Trudeau V.L., and Moon T.W. Waterborne gemfifrozil challenges the hepatic antioxidant defense system and down-regulates peroxisome proliferator-activated receptor beta (PPARbeta) mRNA levels in male goldfish (Carassius auratus). Toxicology 228 (2006) 140-150
25. Montezinho L.P., Mork A., Duarte C.B., Penschuck S., Geraldes C.F., and Castro M.M. Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors. Bipolar Disord. 9 (2007) 290-297
26. Nigro M., Falleni A., Barga I.D., Scarcelli V., Lucchesi P., Regoli F., and Frenzilli G. Cellular biomarkers for monitoring estuarine environments: transplanted versus native mussels. Aquat. Toxicol. 77 (2006) 339-347
27. Oetken M., Nentwig G., Löffler D., Ternes T., and Oehlmann J. Effects of pharmaceuticals on aquatic invertebrates. Part I. The antiepileptic drug carbamazepine. Arch. Environ. Contam. Toxicol. 49 (2005) 353-361
28. Quinn B., Gagnè F., and Blaise C. Oxidative metabolism activity in Hydra attenuata exposed to carbamazepine. Fresenius Environ. Bull. 13 (2004) 1-6
29. Quinn B., Gagnè F., and Blaise C. The effects of pharmaceuticals on the regeneration of the cnidarian Hydra attenuata. Sci. Total Environ. 402 (2008) 62-69
30. Rohlff C., and Glazer R.I. Regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cell Signal. 7 (1995) 431-443
31. Santos N.A., Medina W.S., Martins N.M., Rodrigues M.A., Curti C., and Santos A.C. Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicol. In Vitro 22 (2008) 1820-1824
32. Stamatelatou K., Frouda C., Fountoulakis M.S., Drillia P., Kornaros M., and Lyberatos G. Pharmaceuticals and health care products in wastewater effluents: the example of carbamazepine. Water Sci. Technol.: Water Supply 3 (2003) 131-137
33. Suwalsky M., Mennickent S., Norris B., Villena F., and Sotomayor C.P. Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicol. In Vitro 20 (2006) 1363-1369
34. UNEP/RAMOGE. Manual of the Biomarkers Recommended for the MED POL Biomonitoring Programme (1999), UNEP/RAMOGE, Athens, Greece
35. Valbonesi P., Caselli F., Capuzzo A., and Fabbri E. Modulation of adenylyl cyclase activity in the gills of Tapes philippinarum. J. Exp. Zool. 301 (2004) 952-960
36. Viarengo A., Lowe D., Bolognesi C., Fabbri E., and Koehler A. The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms. Comp. Biochem. Physiol. 146C (2007) 281-300
37. Zhang Y., Geissen S.U., and Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73 (2008) 1151-1161